NGL Fine-Chem Ltd. (NGLFINE)
MSE XNSE Primary MSE Summary
NGLFINE Chart
NGL Fine-Chem Ltd. (NGLFINE) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has NGL Fine-Chem Ltd. ever had a stock split?
NGL Fine-Chem Ltd. Profile
| Chemicals Industry | Materials Sector | Mr. Rahul Jayant Nachane ACA, B. Com, DBF, MMS CEO | MSE Exchange | INE887E01022 ISIN |
| IN Country | 520 Employees | 18 Aug 2026 Last Dividend | - Last Split | - IPO Date |
Overview
NGL Fine-Chem Limited is a prominent pharmaceutical company with a global presence, specializing in the manufacture and sale of pharmaceuticals and intermediates geared towards veterinary and human health. Since its inception in 1981, the organization has built a formidable reputation for its contribution to health care, offering a wide range of active pharmaceutical ingredients (APIs) and other pharmaceutical preparations. Headquartered in Mumbai, India, NGL Fine-Chem Limited stands as a significant player in the pharmaceutical industry, emphasizing both quality and innovation in its offerings.
Products and Services
At the core of its product portfolio, NGL Fine-Chem Limited features an extensive array of active pharmaceutical ingredients and intermediate products tailored for a variety of applications in animal and human health. The company is known for its production of specialty chemicals and finished dosage forms, including granules and tablets. Below is a highlight of their offerings:
- Active Pharmaceutical Ingredients for Animal Health: Includes diminazene aceturate, diminazene diaceturate, homidium chloride, nitroxynil, clorsulon, parvaquone, buparvaquone, isometamidium chloride hydrochloride, toldimfos sodium, butaphosphan, imidocarb dipropionate, triclabendazole, ractopamine HCl, S-methoprene, praziquantel, toltrazuril, decoquinate, flunixin meglumine, carprofen, fenbendazole, amitraz, xylazine hydrochloride, and marbofloxacin. These ingredients are crucial for managing diseases and facilitating the health and well-being of animals.
- Active Pharmaceutical Ingredients for Human Health: Features nitazoxanide and atovaquone, focusing on treating a variety of infections and diseases in humans, underpinning the company's commitment to contributing to public health.
- Intermediate Products and Specialty Chemicals: The company produces a range of intermediate products that are essential in the synthesis of complex pharmaceuticals, alongside specialty chemicals that find applications in various pharmaceutical processes.
- Finished Dosage Forms: NGL Fine-Chem Limited also specializes in the formulation and manufacturing of finished dosage forms, including granules and tablets, designed to facilitate ease of use and enhance patient compliance.
